x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

touchPODCAST

Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare

science

All Episodes

13:57

touchMDT for touchONCOLOGY - What are the key data...

touchPODCAST ·

2024/11/13

touchMDT for touchONCOLOGY What are the key data for immune checkpoint inhibitors (ICIs) in the treatment of limited-stage small cell lung cancer (LS-SCLC)? Listen to experts Dr Jacob Sands and Prof. Suresh Senan discuss the latest data for ICIs in LS-SCLC, including data released at key congresses in 2024, and share their clinical insights. The multidisciplinary team Medical oncologist – Dr Jacob Sands Dana-Farber Cancer Institute, Boston, MA, USA Radiation oncologist – Prof. Suresh

en

14:53

touchMDT for touchONCOLOGY - What is the rationale...

touchPODCAST ·

2024/11/13

touchMDT for touchONCOLOGY What is the rationale for using immune checkpoint inhibitors (ICIs) in limited-stage small cell lung cancer (LS-SCLC)? Listen to experts Dr Lizza Hendriks and Prof. Suresh Senan discuss the rationale for using ICIs in LS-SCLC, including relevant evidence from clinical trials in extended-stage SCLC and LS-SCLC, and review the novel and emerging late-phase ICIs for LS-SCLC. The multidisciplinary team: Pulmonologist – Dr Lizza Hendriks, Maastricht University Medical Center,

en

33:06

Vaccination strategies for pneumococcal disease

touchPODCAST ·

2024/11/05

touchEXPERT OPINIONS for touchINFECTIOUS DISEASES In this activity, Prof. Antoni Torres, a leading expert in respiratory infections, discusses the burden of pneumococcal disease in vulnerable patient populations, the evolving landscape of Streptococcus pneumoniae subtypes and the role that next-generation vaccines can play in preventing severe pneumococcal infections. The expert Prof. Antoni Torres, University of Barcelona, Spain This touchPODCAST is for HCPs outside of the UK. This activity is

en

34:28

Pharmacological management of agitation in...

touchPODCAST ·

2024/10/24

touchPANEL DISCUSSION for touchNEUROLOGY Listen to a panel of leading experts discuss best practice in the management of agitation in Alzheimer’s dementia and the potential of new pharmacological approaches that target aspects of the underlying pathophysiology. The experts Prof. Jeffrey Cummings, University of Nevada, Las Vegas, NV, USA Prof. Krista Lanctôt, University of Toronto, ON, Canada Prof. James Galvin, University of Miami, FL, USA This touchPODCAST is for HCPs outside of the UK

en

35:33

touchIN CONVERSATION - Pulmonary arterial...

touchPODCAST ·

2024/10/24

touchIN CONVERSATION for touchCARDIOListen to Prof. Manreet Kanwar in conversation with Prof. Jean-Luc Vachiéry, two experts in pulmonary arterial hypertension who are practicing in the USA and Belgium, respectively. They respond to questions submitted by the HCP audience and provide expert insights into the diagnosis of pulmonary arterial hypertension, patient risk stratification to support treatment decision-making and considerations for optimizing patient care in an evolving treatment

en

35:33

touchIN CONVERSATION - Pulmonary arterial...

touchPODCAST ·

2024/10/24

touchIN CONVERSATION for touchRESPIRATORY Listen to Prof. Manreet Kanwar in conversation with Prof. Jean-Luc Vachiéry, two experts in pulmonary arterial hypertension who are practicing in the USA and Belgium, respectively. They respond to questions submitted by the HCP audience and provide expert insights into the diagnosis of pulmonary arterial hypertension, patient risk stratification to support treatment decision-making and considerations for optimizing patient care in an evolving treatment

en

52:36

Optimizing treatment of CML in the first-line setting...

touchPODCAST ·

2024/10/17

touchCONGRESS for touchONCOLOGYListen to Prof. Gianantonio Rosti, an expert in CML, as he reviews key data presented at the 2024 EHA Hybrid congress and the ESH-iCMLf 26th Annual John Goldman Conference, on tyrosine kinase inhibitors (TKIs) for treating chronic myeloid leukaemia (CML) in the first- and later-line settings. Prof. Rosti is then joined by fellow experts, Prof. Susanne Saussele and Dr Carla Boquimpani, to consider the implications of these data for current and future clinical

en

52:36

Optimizing treatment of CML in the first-line setting...

touchPODCAST ·

2024/10/17

touchCONGRESS for touchHAEMATOLOGY Listen to Prof. Gianantonio Rosti, an expert in CML, as he reviews key data presented at the 2024 EHA Hybrid congress and the ESH-iCMLf 26th Annual John Goldman Conference, on tyrosine kinase inhibitors (TKIs) for treating chronic myeloid leukaemia (CML) in the first- and later-line settings. Prof. Rosti is then joined by fellow experts, Prof. Susanne Saussele and Dr Carla Boquimpani, to consider the implications of these data for current and future clinical

en

14:12

touchMDT: Precision targeting of MET in NSCLC: A...

touchPODCAST ·

2024/10/16

touchMDT for touchONCOLOGY Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations. The multidisciplinary team Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center, Houston, TX, USA Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Medicine, Baltimore, MD, USA Clinical oncology pharmacist: Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA Oncology nurse practitioner: Ms

en

15:59

touchMDT: Precision targeting of MET in NSCLC: A...

touchPODCAST ·

2024/10/16

touchMDT for touchONCOLOGY Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations. The multidisciplinary team Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center, Houston, TX, USA Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Medicine, Baltimore, MD, USA Clinical oncology pharmacist: Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA Oncology nurse practitioner: Ms

en

14:12

touchMDT: Precision targeting of MET in NSCLC: A...

touchPODCAST ·

2024/10/16

touchMDT for touchRESPIRATORY Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations. The multidisciplinary team Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center, Houston, TX, USA Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Medicine, Baltimore, MD, USA Clinical oncology pharmacist: Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA Oncology nurse practitioner: Ms

en

15:59

touchMDT: Precision targeting of MET in NSCLC: A...

touchPODCAST ·

2024/10/16

touchMDT for touchRESPIRATORY Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations. The multidisciplinary team Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center, Houston, TX, USA Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Medicine, Baltimore, MD, USA Clinical oncology pharmacist: Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA Oncology nurse practitioner:

en

16:22

Targets in early NSCLC: A focus on EGFR-mutant...

touchPODCAST ·

2024/10/15

touchFOCUS for touchONCOLOGY Listen to Dr Jennifer Carlisle, an expert in lung cancer, as she answers a series of questions on the targeted perioperative treatment strategies and best practices for patients with resectable and unresectable early-stage EGFR-mutant NSCLC. She also discusses how the evolving treatment landscape impacts biomarker testing and the importance of multidisciplinary care for optimizing outcomes in these patients. The expert Dr Jennifer Carlisle, Winship Cancer Institute of

en

57:31

Targeting BCMA in multiple myeloma: Insights from...

touchPODCAST ·

2024/10/07

touchCONGRESS for touchONCOLOGY Listen to multiple myeloma expert Prof. María-Victoria Mateos review key data for BCMA-targeting agents in the treatment of multiple myeloma presented at the international Controversies in Multiple Myeloma (COMy) and European Hematology Association (EHA) 2024 congresses. Prof. Mateos is then joined by fellow experts Dr Rakesh Popat and Prof. Evangelos Terpos to discuss how these data may apply in clinical practice. Overview Data reviews with Prof. Mateos,

en

57:31

Targeting BCMA in multiple myeloma: Insights from...

touchPODCAST ·

2024/10/07

touchCONGRESS for touchHAEMATOLOGY Listen to multiple myeloma expert Prof. María-Victoria Mateos review key data for BCMA-targeting agents in the treatment of multiple myeloma presented at the international Controversies in Multiple Myeloma (COMy) and European Hematology Association (EHA) 2024 congresses. Prof. Mateos is then joined by fellow experts Dr Rakesh Popat and Prof. Evangelos Terpos to discuss how these data may apply in clinical practice. Overview Data reviews with Prof. Mateos,

en

33:45

Innovations in glaucoma care: Targeting...

touchPODCAST ·

2024/10/07

touchEXPERT OPINIONS for touchOPHTHALMOLOGY Listen to leading experts describe the pathophysiology of open-angle glaucoma and discuss how it is targeted by current and emerging treatment options, while providing insights on how different agents and combinations are used in practice. The experts Angelo P Tanna, MD - Northwestern University Feinberg School of Medicine, Chicago, IL, USA Courtney E Bovee, MD - Bovee Eye, Tampa Bay, FL, USA Joseph F Panarelli, MD - NYU Langone Eye Center, New York, NY,

en

40:07

Experts in dermatology discuss the latest in treating...

touchPODCAST ·

2024/09/30

touchIN CONVERSATION for touchIMMUNOLOGYListen to Prof. Diamant Thaçi in conversation with Dr Benjamin Ungar. They respond to questions submitted by the HCP audience and provide their expert insights regarding managing moderate–severe atopic dermatitis (AD) in children and adolescents, including assessing the severity of AD, selecting systemic therapy, and managing the potential side effects of systemic treatment. This touchPODCAST is for HCPs outside of the UK. This activity is funded by an

en

40:07

Experts in dermatology discuss the latest in treating...

touchPODCAST ·

2024/09/30

touchIN CONVERSATION for touchDERMATOLOGY Listen to Prof. Diamant Thaçi in conversation with Dr Benjamin Ungar. They respond to questions submitted by the HCP audience and provide their expert insights regarding managing moderate–severe atopic dermatitis (AD) in children and adolescents, including assessing the severity of AD, selecting systemic therapy, and managing the potential side effects of systemic treatment. This touchPODCAST is for HCPs outside of the UK. This activity is funded by an

en

18:41

Updates in recurrent/metastatic nasopharyngeal...

touchPODCAST ·

2024/09/26

touchFOCUS for touchONCOLOGY Listen to Prof. Barbara Burtness as she answers a series of questions focused on the evolving role of immune checkpoint inhibitors in the first- and subsequent-line settings for recurrent/metastatic nasopharyngeal carcinoma. The expert Prof. Barbara Burtness, Yale School of Medicine, New Haven, CT, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Coherus BioSciences. This activity is jointly provided by USF

en

12:49

touchMDT – Pruritus in PBC and me: The patient...

touchPODCAST ·

2024/09/26

touchMDT for touchIMMUNOLOGY Pruritus in PBC and me: The patient experience Listen to experts Prof. Gideon Hirschfield and Prof. Sonja Ständer, plus patient advocate Mrs Collette Thain MBE, explore the burden of cholestatic pruritus in patients with primary biliary cholangitis (PBC). The multidisciplinary team and patient advocate: Hepatologist – Prof. Gideon Hirschfield University of Toronto, Toronto, Canada Dermatologist – Prof. Sonja Ständer University of Münster, Münster, Germany Patient

en

532 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter